Evidence map›Paper›PMID 39086047›Full record

ArticleCPT: pharmacometrics & systems pharmacology2024

Automated Poisson regression exposure-response analysis for binary outcomes with PoissonERM.

Yuchen Wang, Luke Fostvedt, Jessica Wojciechowski, Donald Irby, Timothy Nicholas

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuchen WangPfizer Inc, South San Francisco, California, USA.ORCID 0009-0000-2351-2090
Luke FostvedtPfizer Inc, Cambridge, Massachusetts, USA.ORCID 0000-0002-6714-1188
Jessica WojciechowskiPfizer Inc, Groton, Connecticut, USA.ORCID 0000-0002-3302-8742
Donald IrbyPfizer Inc, San Diego, California, USA.
Timothy NicholasPfizer Inc, Groton, Connecticut, USA.ORCID 0000-0001-8863-665X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PoissonERM is an R package used to conduct exposure-response (ER) analysis on binary outcomes for establishing the relationship between exposure and the occurrence of adverse events (AE). While Poisson regression could be implemented with glm(), PoissonERM provides a simple way to semi-automate the entire analysis and generate an abbreviated report as an R markdown (Rmd) file that includes the essential analysis details with brief conclusions. PoissonERM processes the provided data set using the information from the user's control script and generates summary tables/figures for the exposure metrics, covariates, and event counts of each endpoint (each type of AE). After checking the incidence rate of each AE, the correlation, and missing values in each covariate, an exposure-response model is developed for each endpoint based on the provided specifications. PoissonERM has the flexibility to incorporate and compare multiple scale transformations in its modeling. The best exposure metric is selected based on a univariate model's p-value or deviance (

Indexed as

Models, StatisticalDrug-Related Side Effects and Adverse ReactionsHumansPoisson DistributionRegression AnalysisSoftware

Identifiers

PMID39086047
PMCPMC11494912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.